Kyle Potts
Impact in
-
- Cancer Research and Treatments
-
- Virus-based gene therapy research
Papers in
-
- FOXO transcription factor regulation 1
- Oncology 4
- PARP inhibition in cancer therapy 2
- Co-authors
- Mary Hitt (7 shared papers)Ronald B. Moore (3 shared papers)Desmond Pink (3 shared papers)John D. Lewis (3 shared papers)Krista M. Vincent (1 shared paper)David H. Evans (2 shared papers)Shyambabu Chaurasiya (1 shared paper)David Sharon (1 shared paper)
- Journals
- Cancers (1 paper)Journal of Clinical Oncology (1 paper)Advances in Urology (1 paper)Cancer Letters (1 paper)EMBO Molecular Medicine (1 paper)
- Partner nations
- CanadaUnited StatesFinland
In The Last Decade
Kyle Potts
13 papers receiving 110 citations
Peers
Comparison fields: 5 of 49
- Biotechnology 24
- Genetics 60
- Oncology 48
- Virology 5
- Immunology 18
Countries citing papers authored by Kyle Potts
This map shows the geographic impact of Kyle Potts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Potts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Potts more than expected).
Fields of papers citing papers by Kyle Potts
This network shows the impact of papers produced by Kyle Potts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Potts. The network helps show where Kyle Potts may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle Potts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 36 | |
| 2 | 2012 | 22 | |
| 3 | 2016 | 18 | |
| 4 | 2012 | 15 | |
| 5 | 2021 | 7 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 3 | |
| 9 | 2024 | 1 | |
| 10 | 2017 | 1 | |
| 11 | 2019 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2018 | 1 |
About Kyle Potts
Kyle Potts is a scholar working on Molecular Biology, Oncology, Genetics, Epidemiology and Immunology, having authored 13 papers that have together received 114 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Immunotherapy and Immune Responses (3 papers), Cytomegalovirus and herpesvirus research (2 papers), Cancer Research and Treatments (2 papers), Cancer, Lipids, and Metabolism (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), PARP inhibition in cancer therapy (2 papers) and FOXO transcription factor regulation (1 paper). The work is most often cited by research in Biotechnology (24 citations), Genetics (60 citations), Oncology (48 citations), Virology (5 citations) and Immunology (18 citations). Kyle Potts has collaborated with scholars based in Canada, United States and Finland. Frequent co-authors include Mary Hitt, Ronald B. Moore, Desmond Pink, John D. Lewis, Krista M. Vincent, David H. Evans, Shyambabu Chaurasiya, David Sharon, Chao Shi and Michael A. Long. Their work appears in journals such as Cancers, Journal of Clinical Oncology, Advances in Urology, Cancer Letters and EMBO Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.